Enlivex Therapeutics Ltd. (ENLV) Return on Equity (ROE) and Return on Assets (ROA)
Enlivex Therapeutics Ltd. (ENLV) return on equity (ROE) and return on assets (ROA) history. Calculate ROE/ROA in Excel with MarketXLS.
ROE & ROA Data
| Period | ROE | ROA |
|---|---|---|
| 2016-12-31 | -184.18% | -150.72% |
| 2017-12-31 | -29.48% | -26.25% |
| 2018-12-31 | -43.70% | -38.44% |
| 2019-12-31 | -83.18% | -53.44% |
| 2020-12-31 | -33.32% | -29.30% |
| 2021-12-31 | -17.01% | -15.21% |
| 2022-12-31 | -54.64% | -45.92% |
| 2023-12-31 | -68.26% | -55.75% |
| 2024-12-31 | -63.65% | -54.23% |
| 2025-12-31 | 63.85% | 53.10% |
Return on equity divides net income by total shareholder equity at the period end. Return on assets divides the same net income by total assets at the period end. A figure reads N/A when the divisor is missing or not positive, because the ratio is not meaningful then.
Get Enlivex Therapeutics Ltd. Data in Excel
Stream real-time stock prices and financials directly into your spreadsheets with MarketXLS.
Try: =hf_Return_on_Average_Equity("ENLV", 2024)
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Volume |
| 2 | ENLV | $1.58 | +0.00% | 0.45M |
| 3 | ||||
| 4 | ||||
| 5 |